Indian Journal of Urology (Apr 2024)

Perioperative and functional outcomes following robot-assisted partial nephrectomy: Descriptive analysis of Indian study group on partial nephrectomy database

  • Sudhir Rawal,
  • Arvind Ganpule,
  • Gurpremjit Singh,
  • Nikita Shrivastava,
  • T. A. Kishore,
  • Deepak Dubey,
  • Ravimohan S. Mavuduru,
  • Anant Kumar,
  • Gagan Gautam,
  • Ginil Kumar Pooleri,
  • Mohan Keshavamurthy,
  • Narasimhan Ragavan,
  • Hemang Baxi,
  • Sanjai Kumar Addla,
  • S. Krishnappa Raghunath,
  • Akhil Dahiya,
  • Divya Gupta,
  • Gopal Sharma

DOI
https://doi.org/10.4103/iju.iju_443_23
Journal volume & issue
Vol. 40, no. 2
pp. 121 – 126

Abstract

Read online

Introduction: There is an unmet need for high-quality data for Robot-assisted partial nephrectomy (RAPN) in the Indian population. Indian study group on partial nephrectomy (ISGPN) is a consortium of Indian centers contributing to the partial nephrectomy (PN) database. The current study is a descriptive analysis of perioperative and functional outcomes following RAPN. Methods: For this study, the retrospective ISGPN database was reviewed, which included patients who underwent RAPN for renal masses at 14 centers across India from September 2010 to September 2022. Demographic, clinical, radiological, perioperative, and functional data were collected and analyzed. Ethics approval was obtained from each of the participating centers. Results: In this study, 782 patients were included, and 69.7% were male. The median age was 53 years (interquartile range [IQR 44–62]), median operative time was 180 min (IQR 133–240), median estimated blood loss was 100 mL (IQR 50–200), mean warm ischemia time was 22.7 min and positive surgical margin rates were 2.5%. The complication rate was 16.2%, and most of them were of minor grade. Trifecta and pentafecta outcomes were attained in 61.4% and 60% of patients, respectively. Conclusions: This is the largest Indian multi-centric study using the Indian Robotic PN Collaborative database to evaluate the outcomes of robot-assisted PN, and has proven its safety and efficacy in the management of renal masses.